期刊文献+

树突状细胞活化的CTLs联合5-FU在裸鼠体内外对喉癌的抑制作用

Inhibitive effect of CTLs actived by dendritic cells associated with 5-FU on laryngocarcinoma in vitro and in nude mice
下载PDF
导出
摘要 目的探讨树突状细胞(DCs)活化的细胞毒T细胞(CTLs)联合5-氟尿嘧啶(5-FU)在裸鼠体内外对喉癌的抑制作用。方法MTT法检测DCs激活的CTLs联合5-FU在裸鼠体外对喉癌细胞的抑制作用。裸鼠体内实验分为CTLs治疗组、5-FU治疗组、CTLs/5-FU治疗组及对照组,观察喉癌移植瘤的成瘤率、潜伏期、瘤重及瘤体积。结果治疗组在裸鼠体外都能显著抑制喉癌细胞生长,以CTLs/5-FU治疗组的效果最为显著(P<0.01)。在裸鼠体内实验中,治疗组的成瘤率、瘤体积、瘤重都显著降低,潜伏期延长,以CTLs/5-FU治疗组最为显著(P<0.01)。结论P联合应用DCs激活的CTLs及5-FU比单独应用CTLs或5-FU对喉癌的抑制效果更佳。 Objective To investigate the inhibitive effect of cytotoxic T lymphocytes (CTLs) actived by dendritic cells (DCs) associated with 5-Fluorourac(5-FU) on laryngocarcinoma in vitro and in nude mice. Methods The inhibitive effect of CTLs actived by DCs associated with 5-FU on laryngocarcinoma was detested in vitro by MrI'F methods. In addition, there were four groups in experiments of nude mice: control group, CTLs group, 5-FU group and CTLs/5-FU group. These treatements were given before or after the mice were attacked by laryngocarcinoma cells and the tumor generating rate, the latent phase, the volumn and weight of tumor were observed. Results The inhibitive effect of three therapy groups was significantly increased, especially the CTLs/5-FU group in vitro (P〈0.01). Additionally, in nude mice, the latent phase of therapy groups were increased and the tumor generating rate, the volume and weight of tumor were decreased, especially in the CTLs/5-FU group (P〈0.01). Conclusion CTLs actived by DCs associated with 5-FU are more effective to laryngocarcinoma than CTLs or 5-FU.
作者 张莉 王雪峰
出处 《解剖学研究》 CAS 2008年第3期193-195,共3页 Anatomy Research
基金 辽宁省自然基金(001082)
关键词 树突状细胞 细胞毒T细胞 5-氟尿嘧啶 喉癌 Dendritic cells Cytotoxic T lymphocytes 5-Fluorourac Laryngocarcinoma
  • 相关文献

参考文献15

二级参考文献72

  • 1曾晖,胡梅洁,乔敏敏,章永平,付华,史桂英,张曙,吴云林.苦参碱联合5-氟尿嘧啶抑制胃癌细胞株增殖作用的研究[J].中华消化杂志,2005,25(1):46-47. 被引量:4
  • 2毛应华,糜漫天,许红霞,承海.SP2/0细胞膜抗原负载DC诱导体外特异性CTL效应[J].免疫学杂志,2006,22(1):51-53. 被引量:2
  • 3鞠晓红,方德洋,刘玉侠,于红.脐带血树突状细胞的体外诱导及其特征鉴定[J].中国临床康复,2006,10(9):40-42. 被引量:8
  • 4[2]Charles A,Janeway Jr. The immune system in health & disease. In Mark Walport,ed. Immunobiology [M]. 5th Edition. New York: Garland Publishing,2001.
  • 5[3]Yu Q,Kovacs C, Yue FY,et al. The role of the p38 mitogen- activated protein kinase,extracellular signal- regulated kinase,and phosphoinositide- 3- OH kinase signal transduction pathways in CD40 ligand- induced dendritic cell activation and expansion of virus- specific CD8+ T cell memory responses [J]. J Immunol,2004, 172(10): 6047.
  • 6[4]Shurin MR. Dendritic cells presenting tumor antigen [J]. Cancer Immunol Immunother,1996, 43(3):158.
  • 7[5]Kiertscher SM,Roth MD. Human CD14+ leukocytes acquire the phenotype and function of antigen- presenting dendritic cells when cultured in GM- CSF and IL- 4 [J]. J Leukoc Biol,1996, 59(2):208.
  • 8[6]Murphy GP,Snow P,Simmons SJ,et al. Use of artificial neural networks in evaluating prognostic factors determining the response to dendritic cells pulsed with PSMA peptides in prostate cancer patients [J]. Prostate, 2000, 42(1):67.
  • 9[7]Zitvogel L,Mayordomo JI,Tjandrawan T,et al. Therapy of murine tumors with tumor peptide- pulsed dendritic cells: dependence on T cells,B7 costimulation,and T helper cell 1- associated cytokines [J]. J Exp Med,1996, 183(1):87.
  • 10[8]Nair SK,Snyder D,Rouse BT,et al. Regression of tumors in mice vaccinated with professional antigen- presenting cells pulsed with tumor extracts [J]. Int J Cancer, 1997, 70(6):706.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部